Wayfair Shorts Ease as Co-Founders Keep Selling

Wayfair enters its November 4 earnings report with short positioning that has pulled back sharply from last week's levels, even as the co-founders continue to reduce their personal stakes at a steady clip.

Short interest fell roughly 11% in the past week to 10.0% of the free float, around 10.7 million shares. That reverses the picture from a week ago, when the previous ORTEX preview noted a 24% month-over-month build to 11.9 million shares. The month-over-month figure has compressed to a more modest 11% gain as a result. Among the closest peers, WSM still carries a heavier short burden, while FND shed 5.5% on Friday alone against Wayfair's 3.5% drop, suggesting the wider home retail sector faced some pressure into the weekend. Availability in the borrow market is extraordinarily loose at 5,194% of outstanding short interest, up 16% on the week, meaning shorts face no practical constraint in adding or covering. Borrowing costs have drifted lower to 0.38%.

Options positioning has nudged more defensive than a week ago, though not dramatically so. The put/call ratio is at 0.90, roughly 1.8 standard deviations above its 20-day average of 0.84. That is a mild tilt toward downside hedging relative to recent norms, but it sits well clear of the 52-week high of 1.44 reached in late September. The stock closed at $115.91, up 14% over the past month but down 3.5% on Friday, leaving it just below the analyst consensus target of $123.66.

The co-founder selling is the detail that sharpens the picture. CEO Niraj Shah and co-founder Steven Conine each sold roughly $13 million worth of shares on October 15, all executed under pre-arranged 10b5-1 trading plans. CTO Fiona Tan sold a further $920,000 on October 20, also under a plan. The 90-day net insider position is a sale of 538,570 shares worth approximately $57.9 million. Planned sales carry less signal than discretionary ones, but the scale and clustering are visible. Notably, institutional ownership data from October 15 shows both Shah and Conine reducing their reported holdings by 324,000 shares each since the last filing.

The analyst backdrop has been broadly constructive but divided on conviction. Several firms raised targets after the strong August print, when the stock jumped 20% in a single session, with UBS pushing to $156 and Truist to $135. More recent moves are narrower: Piper Sandler edged its target to $135 and RBC to $96 in the past two weeks, both maintaining existing ratings. The bull case rests on the 8.8 million repeat customer order count, $147 million in adjusted EBITDA, and a forward earnings momentum score in the 99th percentile of the ORTEX universe. Bears point to Same Store Sales guidance of only 4% to 6% for 2026 and the risk of gross margins slipping below 30% later in the year, which would challenge the profitability narrative that drove the August rally.

The November 4 print will test whether the operational metrics that triggered the August rerating have continued to improve, or whether the modest guidance the company itself set is already proving optimistic.